AD pathologies are known to occur at different stages of the disease [4], Aβ accumulation is generally considered an early event that triggers inflammation and contributes to tau pathology, occurring approximately two decades before clinical symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.